ANI Pharmaceuticals | ANIP - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.58B 316M 2026-03
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Heron Therapeutics USD 23.74M 605K 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.44B 132M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Perrigo USD 267.3M 11.4M 2026-03
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03